Resultados de procura - Torrea, Gabriela
- Mostrando 1 - 17 Resultados de 17
-
1
Efficient Tracing of Global Isolates of Yersinia pestis by Restriction Fragment Length Polymorphism Analysis Using Three Insertion Sequences as Probes por Torrea, Gabriela, Chenal-Francisque, Viviane, Leclercq, Alexandre, Carniel, Elisabeth
Publicado 2006Text -
2
-
3
-
4
Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis por Goodall, Ruth L., Sanders, Karen, Bronson, Gay, Gurumurthy, Meera, Torrea, Gabriela, Meredith, Sarah, Nunn, Andrew, Rusen, I. D.
Publicado 2022Text -
5
Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results por Ng, Kamela Charmaine, Meehan, Conor Joseph, Torrea, Gabriela, Goeminne, Léonie, Diels, Maren, Rigouts, Leen, de Jong, Bouke Catherine, André, Emmanuel
Publicado 2018Text -
6
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled t... por Nunn, Andrew J, Rusen, ID, Van Deun, Armand, Torrea, Gabriela, Phillips, Patrick PJ, Chiang, Chen-Yuan, Squire, S Bertel, Madan, Jason, Meredith, Sarah K
Publicado 2014Text -
7
Xpert Ultra Can Unambiguously Identify Specific Rifampin Resistance-Conferring Mutations por Ng, Kamela C. S., van Deun, Armand, Meehan, Conor J., Torrea, Gabriela, Driesen, Michèle, Gabriëls, Siemon, Rigouts, Leen, André, Emmanuel, de Jong, Bouke C.
Publicado 2018Text -
8
Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings por Van Deun, Armand, Bola, Valentin, Lebeke, Rossin, Kaswa, Michel, Hossain, Mohamed Anwar, Gumusboga, Mourad, Torrea, Gabriela, De Jong, Bouke Catharine, Rigouts, Leen, Decroo, Tom
Publicado 2022Text -
9
A Multimethod, Multicountry Evaluation of Breakpoints for Bedaquiline Resistance Determination por Ismail, Nazir Ahmed, Aono, Akio, Borroni, Emanuele, Cirillo, Daniela Maria, Desmaretz, Christel, Hasan, Rumina, Mitarai, Satoshi, Shakoor, Sadia, Torrea, Gabriela, Kaniga, Koné, Omar, Shaheed V.
Publicado 2020Text -
10
Diagnostic performance of smear microscopy and incremental yield of Xpert in detection of pulmonary tuberculosis in Rwanda por Ngabonziza, Jean Claude Semuto, Ssengooba, Willy, Mutua, Florence, Torrea, Gabriela, Dushime, Augustin, Gasana, Michel, Andre, Emmanuel, Uwamungu, Schifra, Nyaruhirira, Alaine Umubyeyi, Mwaengo, Dufton, Muvunyi, Claude Mambo
Publicado 2016Text -
11
Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda por Ssengooba, Willy, de Dieu Iragena, Jean, Komakech, Kevin, Okello, Iginitius, Nalunjogi, Joanitah, Katagira, Winceslaus, Kimuli, Ivan, Adakun, Susan, Joloba, Moses L, Torrea, Gabriela, Kirenga, Bruce J
Publicado 2021Text -
12
Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda por Ssengooba, Willy, Komakech, Kevin, Namiiro, Sharon, Byabajungu, Henry, Nalunjogi, Joanitah, Katagira, Winceslaus, Kimuli, Ivan, Joloba, Moses L, Adakun, Susan, Nakiyingi, Lydia, Torrea, Gabriela, Kirenga, Bruce J
Publicado 2021Text -
13
Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study por Kaniga, Koné, Aono, Akio, Borroni, Emanuele, Cirillo, Daniela Maria, Desmaretz, Christel, Hasan, Rumina, Joseph, Lavania, Mitarai, Satoshi, Shakoor, Sadia, Torrea, Gabriela, Ismail, Nazir Ahmed, Omar, Shaheed V.
Publicado 2020Text -
14
Rifampin Drug Resistance Tests for Tuberculosis: Challenging the Gold Standard por Van Deun, Armand, Aung, Kya J. M., Bola, Valentin, Lebeke, Rossin, Hossain, Mohamed Anwar, de Rijk, Willem Bram, Rigouts, Leen, Gumusboga, Aysel, Torrea, Gabriela, de Jong, Bouke C.
Publicado 2013Text -
15
Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance por Torrea, Gabriela, Ng, Kamela C. S., Van Deun, Armand, André, Emmanuel, Kaisergruber, Justine, Ssengooba, Willy, Desmaretz, Christel, Gabriels, Siemon, Driesen, Michèle, Diels, Maren, Asnong, Sylvie, Fissette, Kristina, Gumusboga, Mourad, Rigouts, Leen, Affolabi, Dissou, Joloba, Moses, De Jong, Bouke C.
Publicado 2019Text -
16
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial por Goodall, Ruth L, Meredith, Sarah K, Nunn, Andrew J, Bayissa, Adamu, Bhatnagar, Anuj K, Bronson, Gay, Chiang, Chen-Yuan, Conradie, Francesca, Gurumurthy, Meera, Kirenga, Bruce, Kiria, Nana, Meressa, Daniel, Moodliar, Ronelle, Narendran, Gopalan, Ngubane, Nosipho, Rassool, Mohammed, Sanders, Karen, Solanki, Rajesh, Squire, S Bertel, Torrea, Gabriela, Tsogt, Bazarragchaa, Tudor, Elena, Van Deun, Armand, Rusen, ID
Publicado 2022Text -
17
Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century por Ngabonziza, Jean Claude S., Rigouts, Leen, Torrea, Gabriela, Decroo, Tom, Kamanzi, Eliane, Lempens, Pauline, Rucogoza, Aniceth, Habimana, Yves M., Laenen, Lies, Niyigena, Belamo E., Uwizeye, Cécile, Ushizimpumu, Bertin, Mulders, Wim, Ivan, Emil, Tzfadia, Oren, Muvunyi, Claude Mambo, Migambi, Patrick, Andre, Emmanuel, Mazarati, Jean Baptiste, Affolabi, Dissou, Umubyeyi, Alaine N., Nsanzimana, Sabin, Portaels, Françoise, Gasana, Michel, de Jong, Bouke C., Meehan, Conor J.
Publicado 2022Text